Showing results (31-40 of 308) with videos related to
Sort By:
Pageof 31
Thrombosis and Haemostasis|July 28, 2012
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?Victor L Serebruany, Dan AtarEuropean Heart Journal|December 17, 2009
The PLATO trial: do you believe in magic?Victor L Serebruany, Dan AtarJournal of Clinical Medicine|July 24, 2021
Misreported Cancer Deaths in PLATO TrialVictor Serebruany, Jean-Francois TanguayJournal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
The in vitro effects of a novel vascular protectant, AGI-1067, on platelet aggregation and major receptor expression in subjects with multiple risk factors for vascular diseaseVictor Serebruany, Alex Malinin, Robert ScottJournal of Thrombosis and Thrombolysis|December 23, 1999
A Randomized, Blinded Study of Two Doses of Novastan(R) (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan(R) and T-PA (MINT) StudySerebruany, Jang, Giugliano, et al.American Journal of Therapeutics|March 6, 2009
Novel antiplatelet agents in development: prasugrel, ticagrelor, and cangrelor and beyondInna Shalito, Olga Kopyleva, Victor SerebruanyCardiology|September 14, 2013
Changes of ticagrelor formulary tiers in the USA: targeting private insurance providers away from government-funded plansVictor L Serebruany, James J DinicolantonioClinical Cardiology|October 2, 2012
Angiotensin receptor blockers worsen renal function and dyspnea on ticagrelor: a potential ticagrelor-angiotensin receptor blocker interaction?James J DiNicolantonio, Victor L SerebruanyThrombosis and Haemostasis|June 8, 2013
Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromesVictor L Serebruany, James J DiNicolantonioThe American Journal of Cardiology|April 4, 1998
Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agentsP A Gurbel, V L SerebruanyPageof 31